# Ambev S.A.: financial statements, quarterly

ABEV · NYSE · CIK 1565025 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/abev.md) · [Financials](/companies/abev/financials.md) · [Filings](/companies/abev/filings.md) · [Insiders](/companies/abev/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/abev/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2014-12-31) | period not labelled (2015-12-31) | period not labelled (2016-12-31) | FY2017 (2017-12-31) | FY2018 (2018-12-31) | FY2019 (2019-12-31) | FY2020 (2020-12-31) | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | not reported | not reported | [7.9](/filings/0001292814-18-000752.md) | [10.4](/filings/0001292814-19-000845.md) | [11.5](/filings/0001292814-20-000888.md) | [11.9](/filings/0001292814-21-001039.md) | [17.1](/filings/0001171843-22-001985.md) | [16.6](/filings/0001292814-23-000992.md) | [14.9](/filings/0001292814-24-000771.md) | [16.1](/filings/0001292814-25-000831.md) | [28.6](/filings/0001292814-26-000640.md) | [18.6](/filings/0001292814-26-000640.md) |
| Current assets | $bn | not reported | not reported | [23.9](/filings/0001292814-18-000752.md) | [24.7](/filings/0001292814-19-000845.md) | [25.3](/filings/0001292814-20-000888.md) | [27.6](/filings/0001292814-21-001039.md) | [35.3](/filings/0001171843-22-001985.md) | [38.6](/filings/0001292814-23-000992.md) | [37.8](/filings/0001292814-24-000771.md) | [36.6](/filings/0001292814-25-000831.md) | [54.2](/filings/0001292814-26-000640.md) | [43.9](/filings/0001292814-26-000640.md) |
| Total assets | $bn | not reported | [90.2](/filings/0001292814-18-000752.md) | [83.8](/filings/0001292814-19-000845.md) | [88.8](/filings/0001292814-20-000888.md) | [95.7](/filings/0001292814-21-001039.md) | [102](/filings/0001171843-22-001985.md) | [125](/filings/0001292814-23-000992.md) | [139](/filings/0001292814-24-000771.md) | [138](/filings/0001292814-25-000831.md) | [133](/filings/0001292814-26-000640.md) | [163](/filings/0001292814-26-000640.md) | [145](/filings/0001292814-26-000640.md) |
| Current liabilities | $bn | not reported | not reported | [28.8](/filings/0001292814-18-000752.md) | [28.7](/filings/0001292814-19-000845.md) | [25.2](/filings/0001292814-20-000888.md) | [25.0](/filings/0001292814-21-001039.md) | [33.5](/filings/0001171843-22-001985.md) | [38.9](/filings/0001292814-23-000992.md) | [40.5](/filings/0001292814-24-000771.md) | [41.0](/filings/0001292814-25-000831.md) | [49.4](/filings/0001292814-26-000640.md) | [45.6](/filings/0001292814-26-000640.md) |
| Total liabilities | $bn | not reported | not reported | [37.2](/filings/0001292814-18-000752.md) | [38.9](/filings/0001292814-19-000845.md) | [38.3](/filings/0001292814-20-000888.md) | [39.2](/filings/0001292814-21-001039.md) | [50.0](/filings/0001171843-22-001985.md) | [54.6](/filings/0001292814-23-000992.md) | [54.6](/filings/0001292814-24-000771.md) | [52.5](/filings/0001292814-25-000831.md) | [62.9](/filings/0001292814-26-000640.md) | [56.3](/filings/0001292814-26-000640.md) |
| Shareholders' equity | $bn | [43.6](/filings/0001292814-18-000752.md) | [50.3](/filings/0001292814-19-000845.md) | [44.8](/filings/0001292814-18-000752.md) | [46.0](/filings/0001292814-19-000845.md) | [56.2](/filings/0001292814-20-000888.md) | [61.3](/filings/0001292814-21-001039.md) | [73.8](/filings/0001171843-22-001985.md) | [82.6](/filings/0001292814-23-000992.md) | [82.0](/filings/0001292814-24-000771.md) | [79.0](/filings/0001292814-25-000831.md) | [98.6](/filings/0001292814-26-000640.md) | [87.9](/filings/0001292814-26-000640.md) |

- Cash and equivalents: ifrs-full:CashAndCashEquivalents
- Current assets: ifrs-full:CurrentAssets
- Total assets: ifrs-full:Assets
- Current liabilities: ifrs-full:CurrentLiabilities
- Total liabilities: ifrs-full:Liabilities
- Shareholders' equity: ifrs-full:Equity, ifrs-full:EquityAttributableToOwnersOfParent

Shares outstanding: 15,761,638,756 at 2025-12-31, from the cover of the [20-F filed 2026-03-03](/filings/0001292814-26-000640.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:43 ET. No prices; not investment advice.